Theradaptive
-
Biologics
Theradaptive Strengthens Executive Team with Hire of Frank Vizesi as Chief Scientific Officer
Dr. Frank Vizesi, Ph.D. Frank brings over 20 years experience in cutting-edge orthobiologics research, with previous roles at NuVasive, SeaSpine…
Read More » -
Biologics
Theradaptive to Expand Global Clinical Trials After Receiving Full Ethics Approval in Australia for OsteoAdapt SP
Theradaptive can now enroll patients at each site in Australia listed with Bellberry as part of its global clinical study for OsteoAdapt…
Read More » -
Biologics
Theradaptive Awarded DOD Clinical Trial Award of up to $7.4 Million
FREDERICK, Md., Sept. 26, 2023 /PRNewswire/ — Today, Theradaptive, a leading biopharmaceutical company using protein engineering to create targeted therapeutics, has been awarded…
Read More » -
Biologics
3D Systems & Theradaptive Establish Commercial Partnership to Advance Orthopedic & Soft Tissue Repair Using Breakthrough Regenerative Therapeutics
Theradaptive’s proprietary protein-engineering platform produces targeted therapeutics that can be used to coat implants, devices to achieve hyper-local deliveryTheradaptive’s innovative…
Read More » -
Financial
U.S. Department of Defense Awards Theradaptive $4 Million Contract for Its OsteoAdapt Regenerative Therapeutic Program
FREDERICK, Md., March 1, 2023 /PRNewswire/ — Today, Theradaptive, a leading biotechnology company specializing in therapeutic delivery platforms, announces a Technology & Therapeutic Development…
Read More » -
Regulatory
FDA Grants Theradaptive Breakthrough Medical Device Designation
FREDERICK, Md., Nov. 19, 2021 /PRNewswire/ — Theradaptive, a privately held biopharmaceutical company pioneering a new class of regenerative implants announced that…
Read More »